Found 0 matching trials
IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC PHASE2 This is a prospective, single-armed, open label study on the efficacy and s...
Show More Location
Beijing Tumor Hospital
Learn More & Join Trial
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) N/A An observational time and motion study in a clinical oncology setting is ut...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly PHASE3 This study evaluated the safety and efficacy of an increased frequency of o...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Prediction of Tumor Shrinkage in Acromegaly N/A In the last two decades, somatostatin analogs have become a cornerstone of ...
Show More Location
Department of Molecular and Clinical Endocrinology and Oncology, University Federico II of Naples
Learn More & Join Trial
Safety Study of Octreotide Injection to Prevent GI Bleeding in Patients With Left Ventricular Assist Device (LVAD) PHASE1 The investigators hypothesize that octreotide LAR (Long Acting Release) saf...
Show More Location
Virginia Commonwealth University Health System
Learn More & Join Trial
Tolvaptan-Octreotide LAR Combination in ADPKD PHASE2 Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a leading cause of ...
Show More Location
CRC per le Malattie Rare Aldo e Cele Daccò
Learn More & Join Trial
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer PHASE2 Diarrhoea is the most commonly reported adverse event (AE) associated with ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR PHASE4 The purpose of this study is to assess the efficacy, safety and patient acc...
Show More Location
Westmead Hospital
Learn More & Join Trial
Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects PHASE4 The purpose of the study is to assess the efficacy of an extended injection...
Show More Location
Universidade Federal do Rio de Janeiro - Department of Internal Medicine - Section of Endocrinology - Neuroendocrine Research Center
Learn More & Join Trial
Gastrointestinal Motility in Patients With Neuroendocrine Tumors N/A We will study the total gastrointestinal transit time (GITT), gastric empty...
Show More Location
Analfysiologisk afsnit, Aarhus University Hospital, Tage Hansensgade, entrance 11A
Learn More & Join Trial